Brief Description
Drug delivery based on microstructural devices that administer therapeutic agents to selected target sites for treatment.
Iris Micromedical was focused on the development of UC Berkeley Associate Professor of Engineering Mauro Ferrari's silicon particulate technology for the intravascular targeted treatment of cancer imedd.
Four years after founding Iris Micromedical, Dr. Ferrari moved to Ohio State University as a professor of bioengineering, internal medicine, and mechanical engineering, and reformed the company as IMedd, Inc.
Timeline
- 1995. Company founded
- 1999. The company ceased operations as Iris Micromedical. Dr. Ferrari reformed the company as IMedd, Inc., with a license to the UC Berkeley intellectual property that had been previously licensed to Iris Micromedical.
Inventors
Mauro Ferrari, Chris Keller